August 2012 Issue

IN THIS ISSUE:     PRINT VERSION


  • Statin Medications No Longer Require Routine Lab Monitoring
  • New Drug Update: Dificid® (fidaxomicin)
  • Falls-Everyone’s Responsibility!
  • Usage of Flomax® (tamsulosin) in Women

Statin Medications No Longer Require Routine Lab Monitoring

In the past, patients have had liver function tests performed prior to starting a statin and then every 6 to 12 months thereafter. New labeling does not require routine monitoring during treatment. Read More

New Drug Update: Dificid

An overview of the product and recommendations for treatment. Read More

Falls - Everyones Responsibility

Studies find that one in five newly admitted nursing home patients has a fall within one month, and that higher levels of staffing with certified nursing assistants reduces the risk of patient falls. Read More

Usage of Flomax in Women

Studies have been conducted to verify the effectiveness of tamsulosin in women with BOO symptoms and have found that tamsulosin is a suitable option for initial treatment. Read More